The Development and Validation of a Simple HPLC-UV Method for the Determination of Vancomycin Concentration in Human Plasma and Application in Critically Ill Patients
Molecules · 2025
DOI: 10.3390/molecules30051062 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift Molecules, 2025. Verfasst von Asma Aboelezz und 4 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, AB T6G 2E1, Canada. Hauptthemen laut MEDLINE: Vancomycin, Anti-Bacterial Agents. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University Hospital Foundation, Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, University Hospital Foundation (UHF), Edmonton, Alberta, Canada.
Abstract (Originalsprache)
Vancomycin is an antimicrobial agent that exhibits high efficacy against Gram-positive bacteria. The importance of therapeutic drug monitoring (TDM) for vancomycin has been substantiated in specific patient cohorts, underscoring the significance of determining vancomycin plasma levels. This study presents the development and validation of a simple, reproducible, and practical approach for quantifying vancomycin levels in human plasma samples through high-performance liquid chromatography (HPLC). Deproteinization of plasma samples (0.3 mL) was achieved using 10% perchloric acid. The chromatographic separation was achieved using a C18 column. The mobile phase, consisting of phosphate buffer and acetonitrile (90:10, v/v), was run at a flow rate of 1 mL/min. Ultraviolet detection was conducted at a wavelength of 192 nm and the method was linear in the range of 4.5–80 mg/L (r2 > 0.99). Inter- and intra-day assay precision and accuracy were determined to be within the acceptable range. The run time was noted to be 10 min. This method was evaluated using different greenness tools, which indicated that the method is environmentally friendly. Our method was effectively applied to analyze vancomycin concentrations in critically ill patients. Thus, our approach has the potential for practical implementation in routine TDM procedures.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, AB T6G 2E1, Canada.
- Department of Pharmacy, Uppsala University, SE 751 23 Uppsala, Sweden.
ORCID-Profile: Sherif Hanafy Mahmoud
Förderung
- University Hospital Foundation
- Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta
- University Hospital Foundation (UHF), Edmonton, Alberta, Canada
- Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, AB, Canada
Zitieren
APA
Aboelezz, A., Tesfamariam, N. S., Kharouba, M., Gligoric, T., & Mahmoud, S. H. (2025). The Development and Validation of a Simple HPLC-UV Method for the Determination of Vancomycin Concentration in Human Plasma and Application in Critically Ill Patients. Molecules. https://doi.org/10.3390/molecules30051062
Vancouver
Aboelezz A, Tesfamariam NS, Kharouba M, Gligoric T, Mahmoud SH. The Development and Validation of a Simple HPLC-UV Method for the Determination of Vancomycin Concentration in Human Plasma and Application in Critically Ill Patients. Molecules. 2025. doi:10.3390/molecules30051062
BibTeX
@article{Aboelezz2025,
author = {Aboelezz, Asma and Tesfamariam, Novel Solomon and Kharouba, Maged and Gligoric, Tamara and Mahmoud, Sherif Hanafy},
title = {The Development and Validation of a Simple HPLC-UV Method for the Determination of Vancomycin Concentration in Human Plasma and Application in Critically Ill Patients},
journal = {Molecules},
year = {2025},
doi = {10.3390/molecules30051062}
}
EUVIMED